Skip to main content

Table 1 Patient characteristics

From: A novel miRNA biomarker panel associated with mortality in pediatric patients with ARDS

  All patients
(n = 235)
Survivors
(n = 43)
Non-survivors (n = 20) p-value
Age, years (IQR) 4.1 (1.0–11.5) 8.9 (1.6–13.6) 10.4 (2.2–12.7) 0.92
Gender, male (%) 125 (53.2) 27 (62.8) 15 (75.0) 0.34
ARDS cause     0.40
 Pulmonary cause (%) 139 (59.1) 27 (62.8) 14 (70.0)  
 Non-pulmonary cause (%) 94 (40.0) 16 (37.2) 5 (25.0)  
Race (%)     0.66
 African-American 17 (7.2) 4 (9.3) 1 (5.0)  
 Asian/Pacific Islander 15 (6.4) 5 (11.6) 2 (10.0)  
 Caucasian 160 (68.1) 19 (44.2) 6 (30.0)  
 Latino 84 (35.7) 11 (25.6) 8 (40.0)  
 Other 43 (18.3) 4 (9.3) 3 (15.0)  
Type of respiratory support (%)     0.45
 Mechanical ventilation   36 (83.7) 16 (80.0)  
 High frequency oscillation   1 (4.7) 2 (10.0)  
 CPAP/BiPAP   5 (11.6) 1 (5.0)  
 High flow nasal cannula   1 (4.7) 1 (5.0)  
PRISM score (IQR) 12 (7–20) 12 (5.5–17) 15 (9–19.25) 0.11
Vasopressor use (%)   12 (27.9) 9 (45.0) 0.18